Lilly´s Nordic manager on Mounjaro launch in Sweden: "Patients deserve respect"

Another blockbuster diabetes and obesity drug has made its way into the Swedish market – with promises of a stable supply and availability for patients. “What we see is a significant unmet need, so we are expecting to have quite a good welcoming

“Unfortunately, we are not strong when it comes to conducting clinical trials”

The number of company-initiated clinical trials conducted in Sweden has been declining in recent years. In mid-March, a government inquiry was presented that aimed to find answers and solutions to this downward trend. One of the proposals was a stable

Höstens mest lästa krönikor

Här nedan läser du de mest lästa krönikorna i Life Science Sweden och systertidningen Medtech Magazine från hösten och vintern.

He is zooming in on topical preparations

According to Zelmic CEO David Sagna, topical products in drug development is a growing market, and to keep pace with the development, the company is awaiting approval for its new GMP facility.

Amorphous materials take centre stage when Orexo develops new formulations

Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive properties of the material, and it also cracks some of the problems,” says the company’s Research and Development Manager Robert Rönn.

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advances have come about thanks to completely random incidents and the open-mindedness of scientists who were ready to think outside the box.

Take off for this year's fair

More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performers have companies in phase III, according to Biotech Scandinavia's survey.

Dry blood DNA storage on a matrix

Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.

How to get the most out of the fair

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.